These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33267791)

  • 61. RCAN1 regulates vesicle recycling and quantal release kinetics via effects on calcineurin activity.
    Zanin MP; Mackenzie KD; Peiris H; Pritchard MA; Keating DJ
    J Neurochem; 2013 Feb; 124(3):290-9. PubMed ID: 23134420
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of adenylate cyclase by forskolin increases the protein stability of RCAN1 (DSCR1 or Adapt78).
    Seo SR; Kim SS; Chung KC
    FEBS Lett; 2009 Oct; 583(19):3140-4. PubMed ID: 19755121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. RCAN1 regulates vascular branching during Xenopus laevis angiogenesis.
    Fujiwara M; Hasebe T; Kajita M; Ishizuya-Oka A; Ghazizadeh M; Kawanami O
    J Vasc Res; 2011; 48(2):104-18. PubMed ID: 20926891
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-34a targets regulator of calcineurin 1 to modulate endothelial inflammation after fetal cardiac bypass in goat placenta.
    Yuan HY; Zhou CB; Chen JM; Liu XB; Wen SS; Xu G; Zhuang J
    Placenta; 2017 Mar; 51():49-56. PubMed ID: 28292468
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modulation of calcineurin activity in mouse brain by chronic oral administration of cyclosporine A.
    Liu H; Tu L; Wang Q; Sun Y; Ma Y; Cen J; Wei Q; Luo J
    IUBMB Life; 2013 May; 65(5):445-53. PubMed ID: 23436429
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulator of Calcineurin 1 helps coordinate whole-body metabolism and thermogenesis.
    Rotter D; Peiris H; Grinsfelder DB; Martin AM; Burchfield J; Parra V; Hull C; Morales CR; Jessup CF; Matusica D; Parks BW; Lusis AJ; Nguyen NUN; Oh M; Iyoke I; Jakkampudi T; McMillan DR; Sadek HA; Watt MJ; Gupta RK; Pritchard MA; Keating DJ; Rothermel BA
    EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30389725
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RCAN1.4 mediates high glucose-induced matrix production by stimulating mitochondrial fission in mesangial cells.
    Chen HM; Dai JJ; Zhu R; Sang XY; Peng FF; Yu H; Zhang BF
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894838
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions.
    Forte M; Palmerio S; Bianchi F; Volpe M; Rubattu S
    J Mol Med (Berl); 2019 May; 97(5):579-591. PubMed ID: 30863992
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.
    Zhang G; Chen Z; Zhang Y; Li T; Bao Y; Zhang S
    Neoplasma; 2020 May; 67(3):461-472. PubMed ID: 32122140
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RCAN1-Calcineurin Axis and the Set-Point for Myocardial Damage During Ischemia-Reperfusion.
    Corbalan JJ; Kitsis RN
    Circ Res; 2018 Mar; 122(6):796-798. PubMed ID: 29700078
    [No Abstract]   [Full Text] [Related]  

  • 71. Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis.
    Wu Y; Song W
    FASEB J; 2013 Jan; 27(1):208-21. PubMed ID: 23038757
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells.
    Alghanem AF; Wilkinson EL; Emmett MS; Aljasir MA; Holmes K; Rothermel BA; Simms VA; Heath VL; Cross MJ
    Angiogenesis; 2017 Aug; 20(3):341-358. PubMed ID: 28271280
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target.
    Zhou H; Li N; Yuan Y; Jin YG; Guo H; Deng W; Tang QZ
    Basic Res Cardiol; 2018 Aug; 113(5):37. PubMed ID: 30094473
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Brain expression of the calcineurin inhibitor RCAN1 (Adapt78).
    Mitchell AN; Jayakumar L; Koleilat I; Qian J; Sheehan C; Bhoiwala D; Hushmendy SF; Heuring JM; Crawford DR
    Arch Biochem Biophys; 2007 Nov; 467(2):185-92. PubMed ID: 17910944
    [TBL] [Abstract][Full Text] [Related]  

  • 75. RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease.
    Li X; Shi L; Xu M; Zheng X; Yu Y; Jin J
    Pediatr Cardiol; 2018 Feb; 39(2):226-235. PubMed ID: 28993896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Growth hormone increases regulator of calcineurin 1-4 (Rcan1-4) mRNA through c-JUN in rat liver.
    Nakata T; Toyoshima Y; Yagi T; Katsumata H; Tokita R; Minami S
    PLoS One; 2020; 15(6):e0235270. PubMed ID: 32589657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives.
    Guo Y; Lu C; Hu K; Cai C; Wang W
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327582
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Emerging role of interleukin-13 in cardiovascular diseases: A ray of hope.
    Qian N; Gao Y; Wang J; Wang Y
    J Cell Mol Med; 2021 Jun; 25(12):5351-5357. PubMed ID: 33943014
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Electromagnetic field and cardiovascular diseases: A state-of-the-art review of diagnostic, therapeutic, and predictive values.
    Wang Y; Zhao ZG; Chai Z; Fang JC; Chen M
    FASEB J; 2023 Oct; 37(10):e23142. PubMed ID: 37650634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inflammatory Burden and Immunomodulative Therapeutics of Cardiovascular Diseases.
    Kao TW; Huang CC
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.